HEALTH CATALYST, INC. (HCAT) News

HEALTH CATALYST, INC. (HCAT): $13.70

0.06 (+0.44%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter HCAT News Items

HCAT News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

HCAT News Highlights

  • For HCAT, its 30 day story count is now at 5.
  • Over the past 22 days, the trend for HCAT's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • The most mentioned tickers in articles about HCAT are MSFT, NXGN and ORCL.

Latest HCAT News From Around the Web

Below are the latest news stories about HEALTH CATALYST INC that investors may wish to consider to help them evaluate HCAT as an investment opportunity.

14 Small-Cap Stocks with High Potential

In this article, we will take a look at the 14 small-cap stocks with high potential. You can skip this part and go to 5 Small-Cap Stocks with High Potential. Small-cap investors took a beating in 2022 as data shows that small-cap stocks are near their all-time lows. According to data from Royce Investment Partners, […]

Yahoo | January 19, 2023

3 Medical Info Systems Stocks Braving Industry-wide Headwinds

Zacks Medical Info Systems industry stocks like 10x Genomics (TXG), NextGen Healthcare (NXGN) and Health Catalyst (HCAT) are expected to gain as COVID-19 severity fades.

Yahoo | January 17, 2023

Health Catalyst Announces a New, External Leadership Assignment for Paul Horstmeier

Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that the leadership of the Church of Jesus Christ of Latter-Day Saints has called Paul Horstmeier, Health Catalyst's Chief Operating Officer, to serve for three years as the Mission President of the Puerto Rico San Juan Mission, beginning in late June 2023.

Yahoo | January 6, 2023

3 Top Tech Stocks That Could Help Make You Rich by Retirement

Tech stocks had as difficult a year as any sector in 2022, with the Nasdaq-100 tech index falling more than 39% over the past year. It's hard to find tech stocks, which are known for their growth, that weren't hit by falling share prices. Health Catalyst (NASDAQ: HCAT), Oracle (NYSE: ORCL), and Microsoft (NASDAQ: MSFT) are all poised to bounce back this year because their financials never really faltered, despite negative market sentiment for the sector.

Yahoo | January 6, 2023

Does This Valuation Of Health Catalyst, Inc. (NASDAQ:HCAT) Imply Investors Are Overpaying?

In this article we are going to estimate the intrinsic value of Health Catalyst, Inc. ( NASDAQ:HCAT ) by projecting its...

Yahoo | December 28, 2022

Health Catalyst to Participate in Upcoming Investor Conference

SALT LAKE CITY, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of Investor Relations and FP&A, will participate in the 41st Annual J.P. Morgan Healthcare Conference, being held in San Francisco, including a presentation on Tuesda

Yahoo | December 20, 2022

Carle Health Partners with Health Catalyst to Achieve Data-Informed Improvement

Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced an expansive, multi-year contract with Carle Health (Carle)—an integrated health system based in Urbana, Illinois that includes five hospitals, multi-specialty physician group practices with more than 1,000 doctors and advanced practice providers, and Health Alliance Medical Plans—deepening its relationship with Health Catalyst to

Yahoo | December 5, 2022

Does Health Catalyst (HCAT) Have the Potential to Rally 61% as Wall Street Analysts Expect?

The consensus price target hints at a 61.5% upside potential for Health Catalyst (HCAT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Yahoo | December 1, 2022

Should You Eliminate Health Catalyst (HCAT) From Your Portfolio?

ClearBridge Investments, an investment management company, published its “ClearBridge Small Cap Growth Strategy” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, the strategy underperformed its benchmark, the Russell 2000 Growth Index, declining about 1%. Overall stock selection and sector allocation drove the strategy to underperform in […]

Yahoo | November 27, 2022

CEO & Director Daniel Burton Just Bought 42% More Shares In Health Catalyst, Inc. (NASDAQ:HCAT)

Those following along with Health Catalyst, Inc. ( NASDAQ:HCAT ) will no doubt be intrigued by the recent purchase of...

Yahoo | November 16, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5765 seconds.